Peregrine Pharmaceuticals reported $6.93M in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acceleron Pharma XLRN:US $ -63662000 59K
Agenus AGEN:US $ -66395000 25.02M
Amgen AMGN:US $ 2333M 204M
AstraZeneca AZN:LN 1.4B 366M
Biocryst Pharmaceuticals BCRX:US $ -29582000 21.8M
Bristol Myers Squibb BMY:US $ 2967M 411M
Celldex Therapeutics CLDX:US $ -13440000 3.2M
Chemocentryx CCXI:US $ -38738000 9.41M
Dicerna Pharmaceuticals DRNA:US $ -40244000 11.14M
Eli Lilly And LLY:US $ 1428.4M 237.8M
Flexion Therapeutics FLXN:US $ -16882000 6.26M
GlaxoSmithKline GSK:LN 1.96B 281M
Immunogen IMGN:US $ -27369000 1.55M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Kindred Biosciences KIN:US -8544000 622K
Macrogenics MGNX:US $ -40279000 11.01M
Mannkind MNKD:US $ -9031000 998K
Merk MRK:US $ 3930M 332M
Minerva Neurosciences NERV:US $ -8963290 1.46M
Newlink Genetics NLNK:US -8664000 47K
Novartis NOVN:VX 3.4B 415M
Novavax NVAX:US $ -345829000 137.2M
Peregrine Pharmaceuticals PPHM:US $ 6.93M 3.84M
Repligen RGEN:US $ 51.46M 10.43M
Xencor XNCR:US $ 9.09M 24.76M